Hyperthermic intravesical chemotherapy with mitomycin‐C for the treatment of high‐risk non‐muscle‐invasive bladder cancer patients

Abstract Objectives The objectives of the study are to explore tolerability, acceptability and oncological outcomes for patients with high‐risk non‐muscle‐invasive bladder cancer (NMIBC) treated with hyperthermic intravesical chemotherapy (HIVEC) and mitomycin‐C (MMC) at our institution. Patients an...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Samantha Conroy, Karl Pang, Ibrahim Jubber, Syed A. Hussain, Derek J. Rosario, Marcus G. Cumberbatch, James W. F. Catto, Aidan P. Noon
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wiley 2023-05-01
Schriftenreihe:	BJUI Compass
Schlagworte:	acceptability high risk hyperthermic intravesical chemotherapy intravesical treatment mitomycin C non‐muscle‐invasive bladder cancer
Online-Zugang:	https://doi.org/10.1002/bco2.203
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!